MedPath

The evaluations of glucose metabolism, bone metabolism, vascular endothelial function and lipid metabolism by the hormone which regulates circadian rhythm in type 2 diabetes.

Not Applicable
Recruiting
Conditions
type 2 diabetes and non diabetes patients
Registration Number
JPRN-UMIN000019018
Lead Sponsor
niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
168
Inclusion Criteria

Not provided

Exclusion Criteria

(1) With diabetic ketoacidosis, diabetic coma and type 1 diabetes (2) With an abnormality in the endocrine hormone levels (3)With severe infections (4)Subjects who have administered melatonin or melatonin receptor agonist (5)Subjects with cognitive decline (less than 23 points in the MMSE). (6)Subjects With malignancy within 5 years (7) Considered as inadequate by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath